Phase 4UnknownINTERVENTIONAL
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov · NCT04027023 · Registry updated: 2021-04-01
- Condition / research focus
- Diabetes Mellitus, Type 2
- Sponsor
- Sciema UG
- Countries with listed sites
- Germany · United States
- Registry dates and results
- Start: 2019-10-30. Completion: 2021-05-31 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Diabetes mellitus Type 2 De-escalation treatment (DET) (drug)
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- NYC Research, Inc.
New York, New York, United States
Site recruitment: Not reported - Mainz, Rhineland-Palatinate, Germany